Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (2)
  • 2023 (9)
  • 2022 (18)
  • 2021 (12)

Subject

  • Drug Trafficking (72)
  • Guilty Plea (36)
  • Guns/Weapons (34)
  • Arrests/Convictions - Major (27)
  • Gangs (22)
  • Synthetic drugs (22)
  • Task Forces/Task Force Officers (18)
  • OCDETF/Task Force (17)
  • Seizures (Drugs/Property) (16)
  • Prescription Drugs (15)
  • Pharmaceuticals/Pharmacists/Physicians (11)
  • Money Laundering (10)
  • Major Law Enforcement Operation (9)
  • Take Back Day (9)
  • Fake Pills (8)
  • Press Conferences (6)
  • International/Foreign Operations (4)
  • Prevention/Education - DEA websites GSAD, JTT etc (4)
  • Fentanyl Awareness (3)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Dark Web- Internet Trafficking (2)
  • Extraditions (2)
  • Outreach/Drug Prevention (2)
  • Overdose (2)
  • Intergovernmental Affairs (1)
  • One Pill Can Kill (1)
  • Terrorism (1)
  • HIDTA (27)
  • Diversion Division (14)

Drug Name

  • Fentanyl (12)
  • Heroin (9)
  • Cocaine (5)
  • Oxycodone (3)
  • Methamphetamine (1)

Field Division

  • New England (61)
  • Washington, DC (43)
  • Seattle (38)
  • Chicago (25)
  • New York (24)
  • Houston (17)
  • Atlanta (14)
  • Miami (13)
  • Sede (11)
  • El Paso (9)
  • New Orleans (8)
  • San Francisco (8)
  • Dallas (7)
  • Rocky Mountain (7)
  • St. Louis (7)
  • Los Angeles (6)
  • Omaha (5)
  • Phoenix (5)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
  • New Jersey (41)
Clear All Results
41 Results - Showing 1 to 10
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
PRESS RELEASE

Owner Of New Jersey Company Admits to Evading U.S. Customs Duties and His Company Agrees to a $3.1 Million Settlement Agreement

NEWARK, N.J. – The owner of a New Jersey company today admitted mislabeling hazardous chemicals entering the United States and evading customs duties, DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. George Volpe, 60, of Roseland, New Jersey, owner...
PRESS RELEASE

Atlantic City Investigation Leads to Arrest and Recovery of Guns and Drugs.

ATLANTIC CITY, NJ - The Drug Enforcement Administration - New Jersey Field Division (DEA NJFD) and the Atlantic City Police Department (ACPD) recently concluded a cooperative investigation leading to the arrest of an Atlantic City resident and the recovery of guns and drugs. On November 15, 2023, detectives of the...
PRESS RELEASE

Passaic County Doctor Charged in Conspiracy to Distribute Opioids

NEWARK, N.J. – A Passaic County, New Jersey, doctor was charged with conspiring to distribute opioids without a legitimate medical reason, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Field Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced. Lisa Ferraro, 65, of Hillsdale, New...
PRESS RELEASE

Toms River Woman Charged with Unauthorized Practice of Medicine, Forgery, Health Care Claims Fraud, and Distribution of a Controlled Dangerous Substance

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division Cheryl Ortiz and Ocean County Prosecutor Bradley D. Billhimer announced that on July 25, 2023, Maria F. Macburnie, aka Marife L. Macburnie, 62, of Toms River, was charged with Practicing Medicine by an Unlicensed...
PRESS RELEASE

Atlantic County Man Sentenced to 14 Years in Prison for Role in Drug DitributionSCHEME

CAMDEN, N.J. – An Atlantic County, New Jersey, man was sentenced to 168 months in prison for his role in a drug distribution scheme, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. Ricardo Clavijo, 42, of...
PRESS RELEASE

Gloucester County Man Admits Healthcare Fraud

CAMDEN, N.J. – A Gloucester County, New Jersey, man today admitted defrauding his employer’s health insurance plan out of more than $4 million by submitting fraudulent claims for medically unnecessary compounded medications, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Cheryl Ortiz and Attorney for the...
PRESS RELEASE

Eight Men Charged with Fentanyl Trafficking

NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced eight men were charged today for their roles in a drug trafficking organization operating in and around Union...
PRESS RELEASE

California Men Admit Conspiring to Distribute Fentanyl and Meth

NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced two California men admitted conspiring to distribute and possess with intent to distribute fentanyl and methamphetamine in New...
PRESS RELEASE

Former Office Manager of New Jersey Medical Practice Admits Conspiring with Doctor to Divert Controlled Substances

NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former office manager of a New Jersey medical practice admitted conspiring with the doctor who owned the...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster